AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026Net selling: insiders sold $3.7M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$3.7M netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Mar 31, 2026
- 2 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 30- Open
- $116.59
- 52-wk high
- $156.26
- High
- $120.68
- 52-wk low
- $86.97
- Low
- $116.59
- Prev close
- $117.51
- Mkt cap
- $4.07B
- P/E
- 15.7x
- Volume
- 403.8K
- Fwd P/E
- 13.6x
- Beta
- 0.63
- P/S
- 2.1x
- P/B
- 2.9x
- Profit margin
- +12.9%
- Op margin
- +19.3%
- ROE
- +18.6%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about CVSA filings
Are insiders buying or selling Covista Inc. (CVSA) stock?
Net selling: insiders sold $3.7M and bought $0 of CVSA stock on the open market in the 90 days to Oct 1, 2026, according to SEC Form 4 filings. $3.7M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Beck, Douglas G. (SVP, GC, Corp. Sec & ISS), who sold $1.3M. The latest filing was on Aug 28, 2026.
Which members of Congress have traded CVSA recently?
None. No member of Congress disclosed a CVSA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this CVSA smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (2)
- BO
Bank of America
$11.1M
added
- FM
FMR LLC
$162.2M
added
What insiders are doing
How top traders are positioned
No tracked top-trader positions in CVSA right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 10.0% above what analysts expected.
Earnings per share
$1.90 expected
Reports Oct 29, 2026, in 28 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $462.3M | $503.4M | $487.0M | $501.4M |
| Cost of what it sold | $200.8M | $205.4M | $210.7M | $216.7M |
| Gross profit | $261.5M | $298.0M | $276.3M | $284.6M |
| What it spent | ||||
| Sales and admin | $175.7M | $182.8M | $184.1M | $188.1M |
| Other operating costs | — | $4.1M | — | — |
| Total operating expenses | $176.0M | $186.8M | $184.1M | $188.1M |
| What was left | ||||
| Operating profit | $85.5M | $111.1M | $92.2M | $96.5M |
| Interest on debt | $11.1M | $10.9M | $13.6M | $8.3M |
| Profit before tax | $76.9M | $101.9M | $77.9M | $88.4M |
| Tax | $15.8M | $25.8M | $20.0M | $16.2M |
| Net profit | $61.8M | $76.4M | $41.6M | $71.7M |
| EBITDA | $98.9M | $128.9M | $112.3M | $117.7M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace